ИСТИНА

Flechon A.

Соавторы: Bokemeyer C., Трякин А.А., Beer T.M., Chi K.N., Fizazi K., Gravis G., Hotte S.J., Jacobs C., Joly F., Malik Z., Saad F., Stewart P., Thomas H.J. показать полностью..., Алексеев Б.Я., Матвеев В.Б., Румянцев А.А., Bedard P.L., Blumenstein B., Castellani A., De Giorgi U., Einhorn L.H., FELEA S., Fankhauser C., Garcia d.X., Giannatempo P., Giovanella U., Gonzalez-Billalabeitia E., Gonzalez‐Billalabeitia E., Hamid A., Huddart R.A., Malison R.L., Michael K., Ottaviani C., Patrikidou A., Pedregal M., Ruiz-Morales J.M., Ruiz‐Morales J.M., Sweeney C.J., Taran M.D., Vecchi A., Wang S., del Muro X.G., Браткова М.В., Кан Э.М., нина ч.в.

5 статей

Количество цитирований статей в журналах по данным Web of Science: 102, Scopus: 106

IstinaResearcherID (IRID): 105380755

Деятельность

• Статьи в журналах

  • 
    • 2020 A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy
    • Fankhauser Christian Daniel, Tran Ben, Pedregal Manuel, Ruiz-Morales José Manuel, Gonzalez-Billalabeitia Egon, Patrikidou Anna, Amir Eitan, Seidel Christoph, Bokemeyer Carsten, Hermanns Thomas, Rumyantsev Alexey, Tryakin Alexey, Brito Margarida, Fléchon Aude, Kwan Edmon M., Cheng Tina, Castellano Daniel, del Muro Xavier Garcia, Hamid Anis A., Ottaviano Margaret, Palmieri Giovanella, Kitson Robert, Reid Alison, Heng Daniel Y.C., Bedard Philippe L., Sweeney Christopher J., Connors Jean M.
    • в журнале European Urology Focus, издательство Elsevier B.V. (Netherlands), том 7 DOI
  • 
    • 2019 Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first‐line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)
    • Tran Ben, Ruiz‐Morales Jose M., Gonzalez‐Billalabeitia Enrique, Patrikidou Anna, Amir Eitan, Seidel Christoph, Bokemeyer Carsten, Fankhauser Christian, Hermanns Thomas, Rumyantsev Alexey, Tryakin Alexey, Brito Margarida, Fléchon Aude, Kwan Edmond Michael, Cheng Tina, Castellano Daniel, Garcia del Muro Xavier, Hamid Anis A., Ottaviano Margaret, Palmieri Giovannella, Kitson Robert, Reid Alison, Heng Daniel Y.C., Bedard Philippe L.
    • в журнале Cancer Medicine, том 9, № 1, с. 116-124 DOI
  • 
    • 2017 Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, phase 3 trial
    • Beer T.M., Hotte S.J., Saad F., Alekseev B., Matveev V., Fléchon A., Gravis G., Joly F., Chi K.N., Malik Z., Blumenstein B., Stewart P.S., Jacobs C.A., Fizazi K.
    • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 18, № 11, с. 1532-1542 DOI
  • 
    • 2016 Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options—An Analysis From the Global Germ Cell Cancer Group
    • Feldman Darren R., Lorch Anja, Kramar Andrew, Albany Costantine, Einhorn Lawrence H., Giannatempo Patrizia, Necchi Andrea, Flechon Aude, Boyle Helen, Chung Peter, Huddart Robert A., Bokemeyer Carsten, Tryakin Alexey, Sava Teodoro, Winquist Eric William, De Giorgi Ugo, Aparicio Jorge, Sweeney Christopher J., Cohn Cedermark Gabriella, Beyer Jörg, Powles Thomas
    • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 34, № 4, с. 345-351 DOI
  • 
    • 2016 Final overall survival (OS) from the AFFINITY phase 3 trial of custirsen and cabazitaxel/prednisone in men with previously treated metastatic castration-resistant prostate cancer (mCRPC)
    • Fizazi K., Hotte S.J., Saad F., Alekseev B., Matveev V.B., Flechon A., Gravis G., Joly F., Chi K.N., Malik Z., Stewart P., Jacobs C., Beer T.M.
    • в журнале Annals of Oncology, издательство Oxford University Press (United Kingdom), том 27, № 6, с. 1-36 DOI